The automated real-time PCR-based test detects DNA from the virus that causes mpox using a dual-target approach and runs on Roche's high-throughput Cobas 6800/8800 systems. The EUL process is intended ...

UK-based Cizzle Biotechnology signed the licensing agreement with its US-based partner, Cizzle Bio, for the commercialization of early cancer detection tests.

Last week, readers were most interested in a story about how priorities for the lab industry could play out depending on election results.

The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.